CA2194678A1 - Use of muramyl peptide compounds - Google Patents

Use of muramyl peptide compounds

Info

Publication number
CA2194678A1
CA2194678A1 CA002194678A CA2194678A CA2194678A1 CA 2194678 A1 CA2194678 A1 CA 2194678A1 CA 002194678 A CA002194678 A CA 002194678A CA 2194678 A CA2194678 A CA 2194678A CA 2194678 A1 CA2194678 A1 CA 2194678A1
Authority
CA
Canada
Prior art keywords
acetyl
acetylmuramyl
alanyl
beta
glucosaminyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002194678A
Other languages
English (en)
French (fr)
Inventor
Philip Ledger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peptech UK Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2194678A1 publication Critical patent/CA2194678A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002194678A 1994-07-11 1995-07-10 Use of muramyl peptide compounds Abandoned CA2194678A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9413935A GB9413935D0 (en) 1994-07-11 1994-07-11 Use of maramyl peptide compounds
GB9413935.9 1994-07-11
CN95194573A CN1155245A (zh) 1994-07-11 1995-07-10 胞壁酰肽化合物的应用

Publications (1)

Publication Number Publication Date
CA2194678A1 true CA2194678A1 (en) 1996-01-25

Family

ID=25743816

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002194678A Abandoned CA2194678A1 (en) 1994-07-11 1995-07-10 Use of muramyl peptide compounds

Country Status (13)

Country Link
EP (1) EP0768888A1 (cs)
JP (1) JPH10505580A (cs)
CN (1) CN1155245A (cs)
AU (1) AU2893595A (cs)
BG (1) BG101126A (cs)
CA (1) CA2194678A1 (cs)
CZ (1) CZ4797A3 (cs)
GB (1) GB9413935D0 (cs)
HU (1) HUT77290A (cs)
IL (1) IL114542A0 (cs)
SK (1) SK2697A3 (cs)
WO (1) WO1996001645A1 (cs)
ZA (1) ZA955763B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046251A1 (fr) * 1997-04-11 1998-10-22 Oleg Vitalievich Kaljuzhin Regulateur immunologique, composition pharmaceutique possedant une activite antitumorale et additif alimentaire
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
WO1999062537A1 (en) * 1998-06-04 1999-12-09 The Rockefeller University Methods and agents for modulating the immune response and inflammation involving monocyte and dendritic cell membrane proteins
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
FR2899466B1 (fr) * 2006-04-07 2008-09-26 Oreal Utilisation de compose c-glycoside agent activateur et regulateur de l'immunite cutanee
EP2094277A4 (en) 2006-10-20 2010-01-20 Kim Soo Youl COMPOSITION FOR THE TREATMENT OF ATOPIC DERMATITIS WITH GLUCOSAMINE AND ITS DERIVATIVES AND METHOD FOR THE TREATMENT OF ATOPIC DERMATITIS THEREWITH
US8603978B2 (en) * 2006-12-01 2013-12-10 The United States of America, as represented by the Secretary, Department of Health and Humand Services Use of muramyl dipeptide (MDP) for treating inflammation
FR2933984B1 (fr) * 2008-07-15 2013-01-04 Univ Bourgogne D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
EP3387005B1 (en) 2015-12-10 2022-08-24 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
CN108883080B (zh) * 2015-12-15 2021-12-21 巴拉特生物技术国际有限公司 胞壁酰肽衍生物化合物、其合成及其用途
EP4308105A1 (en) 2021-03-19 2024-01-24 Trained Therapeutix Discovery, Inc. Compounds for regulating trained immunity, and their methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357322A (en) * 1980-07-29 1982-11-02 Syntex (U.S.A.) Inc. Method of preventing, reducing or inhibiting inflammation
US4698330A (en) * 1983-06-27 1987-10-06 President & Fellows Of Harvard College Somnogenic compositions and method of use
HU205147B (en) * 1989-06-29 1992-03-30 Sandoz Ag Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same
ATE184883T1 (de) * 1991-11-19 1999-10-15 Peptech Uk Ltd Muramylverbindungen zur behandlung von septischem schock
GB9204354D0 (en) * 1992-02-28 1992-04-08 Biokine Tech Ltd Compounds for medicinal use
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
GB9326518D0 (en) * 1993-12-29 1994-03-02 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
SK2697A3 (en) 1997-08-06
CZ4797A3 (en) 1997-07-16
GB9413935D0 (en) 1994-08-31
AU2893595A (en) 1996-02-09
CN1155245A (zh) 1997-07-23
ZA955763B (en) 1997-01-13
HUT77290A (hu) 1998-03-30
HU9700071D0 (en) 1997-02-28
WO1996001645A1 (en) 1996-01-25
IL114542A0 (en) 1995-11-27
BG101126A (en) 1997-09-30
JPH10505580A (ja) 1998-06-02
EP0768888A1 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
EP0614369B1 (en) Pharmaceutical dipeptide compositions and methods of use thereof
US5789384A (en) Pharmaceutical dipeptide compositions and methods of use thereof
CA2194678A1 (en) Use of muramyl peptide compounds
JP2010509308A (ja) ペプチド及び関連化合物の経皮送達システム
JPH02502826A (ja) 免疫欠損状態の治療のための医薬製剤
AU668088B2 (en) Pharmaceutical dipeptide compositions and methods of use thereof
KR100337977B1 (ko) 약용화합물
KR100266929B1 (ko) 약학적 라이신-함유 폴리펩티드 조성물 및 그의 사용방법
CZ86197A3 (en) Use of muramyl peptide compounds
JP6421141B2 (ja) ペプチド及び関連化合物の経皮送達システム
AU2016213759B2 (en) Transdermal delivery systems of peptides and related compounds
JP2014001237A (ja) ペプチド及び関連化合物の経皮送達システム
WO1999003504A1 (fr) Compositions medicamenteuses destinees au traitement des maladies immunodeficitaires
WO1993012810A1 (en) Pharmaceutical pentapeptide compositions and methods of use thereof

Legal Events

Date Code Title Description
FZDE Discontinued